The Competitive Edge for
Every Government Program Strategy
Market, product, network, and forecast intelligence — all in one platform.
Updated within 12 hours of every CMS release.
ProductIntel™
Know what every competitor is offering, benefit by benefit, plan by plan. Parsed from 5,000+ EOC documents to give you an edge in the market.
NetworktIntel™
See exactly where your network is stronger or weaker than every competitor in your market, down to the individual provider.
MarketIntel™
Track enrollment shifts, competitor moves, and market share changes across every county you operate in. Spot opportunities easily.
Latest Insights from HealthworksAI
Discover original research, competitive analysis, and strategic intelligence
from the HealthWorksAI team — tested against 1,400+ markets.
The MA Industry Just Chose Margin
Seven of the largest MA payers reported Q1 2026. Read across the calls and the message is unambiguous. Here is what each one signaled, what they said collectively, and what it means for your AEP 2027 positioning
Why MA Network Leaders Are Quietly Rewriting the Playbook for 2027
Network adequacy is no longer a competitive position in Medicare Advantage. Here is how leading health plans are moving from compliance to sculpting ahead of 2027 bids.
Alignment Healthcare Q1 2026 Results
The most surprising finding in Elevance Health’s Q1 2026 report is not the 16% adjusted EPS beat—it is the hidden anatomy of that beat. Of the $12.58 adjusted EPS.
Elevance Q1 2026 Earnings Call Insight
The most surprising finding in Elevance Health’s Q1 2026 report is not the 16% adjusted EPS beat—it is the hidden anatomy of that beat. Of the $12.58 adjusted EPS.
Humana Inc. Q1 2026 Earnings Call Insight
The most important signal from Humana’s Q1 2026 results is not the headline EPS but the explicit strategy being telegraphed for 2027 bids: benefit cuts are coming.
Centene Corporation Q1 2026 Earnings Call Insight
Centene’s Q1 2026 results landed roughly $0.50 ahead of its own internal expectations, with adjusted EPS of $3.37 and a 58% beat over Street consensus.